Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan.

Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman SM.

Sci Rep. 2016 Nov 2;6:36482. doi: 10.1038/srep36482.

2.

Region specific lung nodule management practice guideline.

Apperley S, Lam S.

J Thorac Dis. 2016 Sep;8(9):2319-2323. No abstract available.

3.

Risk factors assessment and risk prediction models in lung cancer screening candidates.

Adamek M, Wachuła E, Szabłowska-Siwik S, Boratyn-Nowicka A, Czyżewski D.

Ann Transl Med. 2016 Apr;4(8):151. doi: 10.21037/atm.2016.04.03. Review.

4.

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK.

JAMA. 2016 Jun 7;315(21):2300-11. doi: 10.1001/jama.2016.6255.

5.

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.

Marcus MW, Raji OY, Duffy SW, Young RP, Hopkins RJ, Field JK.

Int J Oncol. 2016 Jul;49(1):361-70. doi: 10.3892/ijo.2016.3499.

6.

Impact of a combined community and primary care prevention strategy on all-cause and cardiovascular mortality: a cohort analysis based on 1 million person-years of follow-up in Västerbotten County, Sweden, during 1990-2006.

Blomstedt Y, Norberg M, Stenlund H, Nyström L, Lönnberg G, Boman K, Wall S, Weinehall L.

BMJ Open. 2015 Dec 18;5(12):e009651. doi: 10.1136/bmjopen-2015-009651.

7.

Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Cui JW, Li W, Han FJ, Liu YD.

Transl Lung Cancer Res. 2015 Jun;4(3):275-86. doi: 10.3978/j.issn.2218-6751.2015.02.05. Review.

8.

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G.

Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.

9.

The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

El-Zein RA, Lopez MS, D'Amelio AM Jr, Liu M, Munden RF, Christiani D, Su L, Tejera-Alveraz P, Zhai R, Spitz MR, Etzel CJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2462-70. doi: 10.1158/1055-9965.EPI-14-0462.

Items per page

Supplemental Content

Support Center